India Poultry Vaccines Market Overview
The India Poultry Vaccines Market is expanding as India’s poultry industry grows and farmers place greater emphasis on disease prevention, flock health, biosecurity, and productivity. Rising poultry production, emerging disease threats, government support, and advances in recombinant and other vaccine technologies are supporting demand for poultry vaccination solutions.
According to the Market Research Future report last updated April 6, 2026, the India Poultry Vaccines Market was valued at USD 102.5 Million in 2024 and is projected to grow from USD 108.85 Million in 2025 to USD 186.5 Million by 2035, registering a CAGR of 5.59% during 2025–2035. Infectious Bronchitis is the largest application segment, while Newcastle Disease is the fastest-growing. Live Attenuated Vaccines dominate the type segment, Recombinant Vaccines are growing rapidly, Intramuscular administration is the largest route, and Broilers represent the largest target-species segment.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.marketresearchfuture.com/reports/india-poultry-vaccines-market-50540
Key players driving innovation and competitiveness in the India Poultry Vaccines Market include:
Zoetis (IN)
Merck Animal Health (IN)
Boehringer Ingelheim (IN)
Hester Biosciences (IN)
Indian Immunologicals (IN)
Venkateshwara Hatcheries (IN)
Ceva Santé Animale (IN)
Alltech (IN)
The market is being shaped by increasing poultry production, emerging avian disease threats, rising awareness of animal health, government biosecurity initiatives, and advances in vaccine development. Recombinant and vector-based technologies are gaining attention for improved efficacy and safety, while stricter quality and regulatory oversight can increase confidence in vaccination. Growing consumer demand for safe poultry products is also encouraging producers to strengthen disease-prevention programs.
The India Poultry Vaccines Market can be segmented by Type into Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, and DNA Vaccines. By Application, it includes Infectious Bronchitis, Newcastle Disease, Avian Influenza, Marek’s Disease, and Coryza. By Target Species, it covers Broilers, Layers, Breeders, and Turkeys. By Route of Administration, it includes Intramuscular, Subcutaneous, Oral, and Intraocular. The report also identifies Liquid as the largest formulation segment and Lyophilized as the fastest-growing formulation.
Purchase the Complete Report for Strategic Insights and Market Forecasts:
https://www.marketresearchfuture.com/reports/india-poultry-vaccines-market-50540
The expansion of India’s poultry sector is creating opportunities for vaccine manufacturers, veterinary pharmaceutical companies, hatcheries, poultry integrators, distributors, diagnostic providers, and research organizations. Customized vaccines for regional disease patterns, digital vaccine-tracking platforms, improved cold-chain logistics, and advanced vaccine technologies can support market differentiation. Strengthening farmer education and biosecurity practices can further expand vaccination adoption.
Recent Developments and Market Trends:
Government initiatives supporting poultry health and biosecurity are encouraging greater adoption of vaccination programs.
Recombinant and vector-based vaccines are gaining attention as producers seek more targeted and effective disease-control solutions.
Awareness campaigns and farmer education are increasing recognition of vaccination’s role in preventing economic losses from poultry diseases.
Digitalization, AI, and data-driven disease-management tools are creating opportunities for better vaccine tracking and flock-health monitoring.
Improved cold-chain and distribution infrastructure is expanding access to vaccines, particularly across rural and emerging poultry-producing regions.
Browse In-depth Market Research Report (Pages, Charts, Tables, Figures):
https://www.marketresearchfuture.com/reports/india-poultry-vaccines-market-50540
Reasons to Buy the Report:
Provides comprehensive insights into the India Poultry Vaccines Market dynamics, trends, opportunities, and growth potential.
Helps identify opportunities across live attenuated, inactivated, recombinant, and DNA vaccines.
Offers detailed segmentation analysis across application, vaccine type, route of administration, target species, and formulation.
Includes competitive intelligence covering major global and India-based poultry vaccine companies.
Supports informed decisions using market forecasts, poultry-production trends, disease risks, regulatory developments, vaccine innovation, and regional opportunities.
Future Outlook:
The future of the India Poultry Vaccines Market will be shaped by rising poultry production, stronger biosecurity practices, emerging disease threats, farmer awareness, and continued vaccine innovation. Live Attenuated Vaccines should remain the dominant type, while Recombinant Vaccines are positioned for strong growth. Infectious Bronchitis should remain the largest application, with Newcastle Disease expanding rapidly. Intramuscular administration will continue to play a major role, while Oral vaccination offers convenience for large-scale operations. Broilers should remain the leading target species, with Layers providing an important growth opportunity. Market Research Future projects the market to reach USD 186.5 Million by 2035 at a CAGR of 5.59%.
➤➤Explore Related Ongoing Coverage:
Veterinary Pharmaceuticals Market
Newcastle Disease Vaccine Market
Veterinary Biotechnology Market
